Skip to main content
Erschienen in:

01.05.2020

Role of rivaroxaban in sunitinib-induced renal injuries via inhibition of oxidative stress-induced apoptosis and inflammation through the tissue nacrosis factor-α induced nuclear factor-κappa B signaling pathway in rats

verfasst von: Naif O. Al-Harbi, Faisal Imam, Mohammad Matar Alharbi, Mohammad Rashid Khan, Wajhul Qamar, Muhammad Afzal, Mohammad Algahtani, Saad Alobaid, Ali Salim Alfardan, Abdulrahman Alshammari, Thamer H. Albekairi, Khalid Saad Alharbi

Erschienen in: Journal of Thrombosis and Thrombolysis | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Abstract

Rivaroxaban (RIVA) inhibits factor Xa and exhibits antithrombotic and anti-inflammatory activities by inhibiting several cellular signaling molecules. Sunitinib (SUN) is FDA approved first-line drug for metastatic renal cancers and advanced cancerous states of gastrointestinal tract. Present hypothesis was aimed to examine the nephroprotective potential of RIVA in SUN-induced nephrotoxicity, mediated through the inhibition of oxidative stress-induced apoptosis and inflammation, via the TNF-α/NFk-B signaling pathways. Wistar rats 200–250 g were selected and divided randomely in 5 groups (n = 6): Group 1 kept as normal control; Group 2 as disease control and exposed to SUN 50 mg/kg thrice-weekly upto 21 days; Groups 3 and 4, were treatment groups and administered SUN 50 mg/kg thrice-weekly as of group 2 and treated with RIVA 5 and 10 mg/kg/daily for 21 days, respectively; and Group 5 fed with RIVA alone (10 mg/kg/daily for 21 days). Serum was separated from blood to estimate serum biochemical parameters and kidney tissues were collected to estimate antioxidant enzyme, mRNA and protein expression. SUN exposure significantly elevated levels of creatinine, urea, uric acid, blood urea nitrogen, albumin, and bilirubin, and decreased serum magnesium and iron levels. Malondialdehyde and catalase levels were significantly increased and glutathione and glutathione reductase levels were significantly decreased. Intracellular levels of caspase-3 and TNF-α were significantly increased; RIVA treatment restored the altered levels. In SUN-exposed animals, western blotting revealed significantly elevated NFk-B, IL-17, and MCP-1 expression, and IKBα levels were significantly downregulated; RIVA restored these levels to normal values.RIVA treatment significantly restored the apoptotic and inflammatory parameters in SUN-damaged renal tissues.

Graphic abstract

Literatur
1.
Zurück zum Zitat Ferguson MA, Vaidya VS, Bonventre JV (2008) Biomarkers of nephrotoxic acute kidney injury. Toxicology 245(3):182–193CrossRef Ferguson MA, Vaidya VS, Bonventre JV (2008) Biomarkers of nephrotoxic acute kidney injury. Toxicology 245(3):182–193CrossRef
2.
Zurück zum Zitat Kohli HS, Bhaskaran MC, Muthukumar T, Thennarasu K, Sud K, Jha V, Gupta KL, Sakhuja V (2000) Treatment-related acute renal failure in the elderly: a hospital-based prospective study. Nephrol Dial Transplant 15:212–217CrossRef Kohli HS, Bhaskaran MC, Muthukumar T, Thennarasu K, Sud K, Jha V, Gupta KL, Sakhuja V (2000) Treatment-related acute renal failure in the elderly: a hospital-based prospective study. Nephrol Dial Transplant 15:212–217CrossRef
3.
Zurück zum Zitat Nagai J, Takano M (2010) Molecular-targeted approaches to reduce renal accumulation of nephrotoxic drugs. Expert Opin Drug Metab Toxicol 6:1125–1138CrossRef Nagai J, Takano M (2010) Molecular-targeted approaches to reduce renal accumulation of nephrotoxic drugs. Expert Opin Drug Metab Toxicol 6:1125–1138CrossRef
4.
Zurück zum Zitat Jhaveri KD, Shah HH, Patel C et al (2014) Glomerular diseases associated with cancer, chemotherapy, and hematopoietic stem cell transplantation. Adv Chronic Kidney Dis 21:48–55CrossRef Jhaveri KD, Shah HH, Patel C et al (2014) Glomerular diseases associated with cancer, chemotherapy, and hematopoietic stem cell transplantation. Adv Chronic Kidney Dis 21:48–55CrossRef
5.
Zurück zum Zitat Perazella MA, Izzedine H (2015) New drug toxicities in the onco-nephrology world. Kidney Int 87:909–917CrossRef Perazella MA, Izzedine H (2015) New drug toxicities in the onco-nephrology world. Kidney Int 87:909–917CrossRef
6.
Zurück zum Zitat Humphreys BD, Soiffer RJ, Magee CC (2005) Renal failure associated with cancer and its treatment: an update. J Am Soc Nephrol 16:151–161CrossRef Humphreys BD, Soiffer RJ, Magee CC (2005) Renal failure associated with cancer and its treatment: an update. J Am Soc Nephrol 16:151–161CrossRef
7.
Zurück zum Zitat Cairo MS, Coiffier B, Reiter A et al (2010) Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus. Br J Haematol 149:578–586CrossRef Cairo MS, Coiffier B, Reiter A et al (2010) Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus. Br J Haematol 149:578–586CrossRef
8.
Zurück zum Zitat Zhu X, Stergiopoulos K, Wu S (2009) Risk of hypertension and renal dysfunction with an angiogenesis inhibitor sunitinib: systematic review and meta-analysis. Acta Oncol 48:9–17CrossRef Zhu X, Stergiopoulos K, Wu S (2009) Risk of hypertension and renal dysfunction with an angiogenesis inhibitor sunitinib: systematic review and meta-analysis. Acta Oncol 48:9–17CrossRef
9.
Zurück zum Zitat Patyna S, Arrigoni C, Terron A, Kim T, Heward JK, Vonderfecht SL, Denlinger R, Turnquist SE, Evering W (2008) Nonclinical safety evaluation of sunitinib: A potent inhibitor of VEGF, PDGF, KIT, FLT3, and RET receptors. Toxicol Pathol 36:905–916CrossRef Patyna S, Arrigoni C, Terron A, Kim T, Heward JK, Vonderfecht SL, Denlinger R, Turnquist SE, Evering W (2008) Nonclinical safety evaluation of sunitinib: A potent inhibitor of VEGF, PDGF, KIT, FLT3, and RET receptors. Toxicol Pathol 36:905–916CrossRef
10.
Zurück zum Zitat Gurevich F, Perazella MA (2009) Renal effects of anti-angiogenesis therapy: update for the internist. Am J Med 122:322–328CrossRef Gurevich F, Perazella MA (2009) Renal effects of anti-angiogenesis therapy: update for the internist. Am J Med 122:322–328CrossRef
11.
Zurück zum Zitat Jhaveri KD, Flombaum CD, Kroog G, Glezerman IG (2011) Nephrotoxicities associated with the use of tyrosine kinase inhibitors: a single-center experience and review of the literature. Nephron Clin Pract 117:c312–c319CrossRef Jhaveri KD, Flombaum CD, Kroog G, Glezerman IG (2011) Nephrotoxicities associated with the use of tyrosine kinase inhibitors: a single-center experience and review of the literature. Nephron Clin Pract 117:c312–c319CrossRef
12.
Zurück zum Zitat O’Farrell AM, Abrams TJ, Yuan HA, Ngai TJ, Louie SG, Yee KW, Wong LM, Hong W, Lee LB, Town A, Smolich BD, Manning WC, Murray LJ, Heinrich MC, Cherrington JM (2003) SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo. Blood 101:3597–3605CrossRef O’Farrell AM, Abrams TJ, Yuan HA, Ngai TJ, Louie SG, Yee KW, Wong LM, Hong W, Lee LB, Town A, Smolich BD, Manning WC, Murray LJ, Heinrich MC, Cherrington JM (2003) SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo. Blood 101:3597–3605CrossRef
13.
Zurück zum Zitat Perez-Gracia JP, Prior C, Guille´n-Grima F, Segura V, Gonzalez A, Panizo A, Melero I, Grande-Pulido E, Gurpide A, Gil-Bazo I, Calvo A (2009) Identification of TNF-a and MMP-9 as potential baseline predictive serum markers of sunitinib activity in patients with renal cell carcinoma using a human cytokine array. Br J Cancer 101:1876–1883CrossRef Perez-Gracia JP, Prior C, Guille´n-Grima F, Segura V, Gonzalez A, Panizo A, Melero I, Grande-Pulido E, Gurpide A, Gil-Bazo I, Calvo A (2009) Identification of TNF-a and MMP-9 as potential baseline predictive serum markers of sunitinib activity in patients with renal cell carcinoma using a human cytokine array. Br J Cancer 101:1876–1883CrossRef
14.
Zurück zum Zitat Fujiwara Y, Ando H, Ushijima K, Horiguchi M, Yamashita C, Fujimura A (2017) Dosing-time-dependent effect of rivaroxaban on coagulation activity in rats. J Pharmacol Sci 134(4):234–238CrossRef Fujiwara Y, Ando H, Ushijima K, Horiguchi M, Yamashita C, Fujimura A (2017) Dosing-time-dependent effect of rivaroxaban on coagulation activity in rats. J Pharmacol Sci 134(4):234–238CrossRef
15.
Zurück zum Zitat Ojima A, Ishibashi Y, Matsui T, Maeda S, Nishino Y, Takeuchi M et al (2013) Glucagon-like peptide-1 receptor agonist inhibits asymmetric dimethylarginine generation in the kidney of streptozotocin-induced diabetic rats by blocking advanced glycation end product-induced protein arginine methyltranferase-1 expression. Am J Pathol 182:132–141CrossRef Ojima A, Ishibashi Y, Matsui T, Maeda S, Nishino Y, Takeuchi M et al (2013) Glucagon-like peptide-1 receptor agonist inhibits asymmetric dimethylarginine generation in the kidney of streptozotocin-induced diabetic rats by blocking advanced glycation end product-induced protein arginine methyltranferase-1 expression. Am J Pathol 182:132–141CrossRef
19.
Zurück zum Zitat Motzer RJ, Hoosen S, Bello CL, Christensen JG (2006) Sunitinib malate for the treatment of solid tumours: a review of current clinical data. Expert Opin Investig Drugs 15:553–561CrossRef Motzer RJ, Hoosen S, Bello CL, Christensen JG (2006) Sunitinib malate for the treatment of solid tumours: a review of current clinical data. Expert Opin Investig Drugs 15:553–561CrossRef
20.
Zurück zum Zitat Murray LJ, Abrams TJ, Long KR, Ngai TJ, Olson LM, Hong W, Keast PK, Brassard JA, O’Farrell AM, Cherrington JM, Pryer NK (2003) SU11248 inhibits tumor growth and CSF-1Rdependent osteolysis in an experimental breast cancer bone metastasis model. Clin Exp Metastasis 20:757–766CrossRef Murray LJ, Abrams TJ, Long KR, Ngai TJ, Olson LM, Hong W, Keast PK, Brassard JA, O’Farrell AM, Cherrington JM, Pryer NK (2003) SU11248 inhibits tumor growth and CSF-1Rdependent osteolysis in an experimental breast cancer bone metastasis model. Clin Exp Metastasis 20:757–766CrossRef
21.
Zurück zum Zitat Sedlak J, Lindsay RH (1968) Estimation of total, protein bound and non-protein bound sulfhydryl groups in tissue with Ellman’s reagent. Anal Biochem 25:192–205CrossRef Sedlak J, Lindsay RH (1968) Estimation of total, protein bound and non-protein bound sulfhydryl groups in tissue with Ellman’s reagent. Anal Biochem 25:192–205CrossRef
22.
Zurück zum Zitat Ding M et al (2000) Department of health and human services, public health service, food and drug administration, center for drug evaluation and research. Pharmacology/toxicology review and evaluation (BAY 59–7939), NDA 22–406. J Cell Sci 113:2409–2419PubMed Ding M et al (2000) Department of health and human services, public health service, food and drug administration, center for drug evaluation and research. Pharmacology/toxicology review and evaluation (BAY 59–7939), NDA 22–406. J Cell Sci 113:2409–2419PubMed
23.
Zurück zum Zitat Zhou Z, Kang YJJ (2000) Cellular and subcellular localization of catalase in the heart of transgenic mice. Histochem Cytochem 48:585–594CrossRef Zhou Z, Kang YJJ (2000) Cellular and subcellular localization of catalase in the heart of transgenic mice. Histochem Cytochem 48:585–594CrossRef
24.
Zurück zum Zitat Carlberg I, Mannervik B (1985) Glutathione reductase. Methods Enzymol 113:484–490CrossRef Carlberg I, Mannervik B (1985) Glutathione reductase. Methods Enzymol 113:484–490CrossRef
25.
Zurück zum Zitat Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275PubMed Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275PubMed
26.
Zurück zum Zitat Borensztajn K, Stiekema J, Nijmeijer S, Reitsma PH, Peppelenbosch MP, Spek CA (2008) Factor Xa stimulates proinflammatory and profibrotic responses in fibroblasts via protease-activated receptor-2 activation. Am J Pathol 172:309–320CrossRef Borensztajn K, Stiekema J, Nijmeijer S, Reitsma PH, Peppelenbosch MP, Spek CA (2008) Factor Xa stimulates proinflammatory and profibrotic responses in fibroblasts via protease-activated receptor-2 activation. Am J Pathol 172:309–320CrossRef
27.
Zurück zum Zitat Grover PK, Miyazawa K, Ryall RL (2004) Renal prothrombin: quantification of mRNA using reverse transcription-polymerase chain reaction in a rat model. Electrophoresis 25(6):797–803CrossRef Grover PK, Miyazawa K, Ryall RL (2004) Renal prothrombin: quantification of mRNA using reverse transcription-polymerase chain reaction in a rat model. Electrophoresis 25(6):797–803CrossRef
28.
Zurück zum Zitat Morse SJ (2014) RNA Extraction and cDNA Preparation, The Fleischman Lab Morse SJ (2014) RNA Extraction and cDNA Preparation, The Fleischman Lab
29.
Zurück zum Zitat Baek SH, Kim H, Lee J, Kim DK, Oh KH, Kim YS, Han JS, Kim TM, Lee SH, Joo KW (2014) Renal adverse effects of sunitinib and its clinical significance: a single-center experience in Korea. Korean J Intern Med 29(1):40–48CrossRef Baek SH, Kim H, Lee J, Kim DK, Oh KH, Kim YS, Han JS, Kim TM, Lee SH, Joo KW (2014) Renal adverse effects of sunitinib and its clinical significance: a single-center experience in Korea. Korean J Intern Med 29(1):40–48CrossRef
30.
Zurück zum Zitat Chen YS, Chen CL, Wang JS (2009) Nephrotic syndrome and acute renal failure apparently induced by sunitinib. Case Rep Oncol 2:172–176CrossRef Chen YS, Chen CL, Wang JS (2009) Nephrotic syndrome and acute renal failure apparently induced by sunitinib. Case Rep Oncol 2:172–176CrossRef
32.
Zurück zum Zitat Arunkumar PA, Viswanatha GL, Radheshyam N, Mukund H, Belliyappa MS (2012) Science behind cisplatin-induced nephrotoxicity in humans: a clinical study. Asian Pac J Trop Biomed 2(8):640–644CrossRef Arunkumar PA, Viswanatha GL, Radheshyam N, Mukund H, Belliyappa MS (2012) Science behind cisplatin-induced nephrotoxicity in humans: a clinical study. Asian Pac J Trop Biomed 2(8):640–644CrossRef
33.
Zurück zum Zitat Kim SY, Moon M (2012) Drug-induced nephrotoxicity and its biomarkers. Biomol Ther (Seoul) 20(3):268–272CrossRef Kim SY, Moon M (2012) Drug-induced nephrotoxicity and its biomarkers. Biomol Ther (Seoul) 20(3):268–272CrossRef
34.
Zurück zum Zitat Aboulthana WM, Ibrahim N (2018) A renoprotective role of chitosan against lithium-induced renal toxicity in rats. Bull Nat Res Centre 42:34CrossRef Aboulthana WM, Ibrahim N (2018) A renoprotective role of chitosan against lithium-induced renal toxicity in rats. Bull Nat Res Centre 42:34CrossRef
35.
Zurück zum Zitat Kakalij RM, Alla CP, Kshirsagar RP, Kumar BH, Mutha SS, Diwan PV (2014) Ameliorative effect of Elaeocarpus ganitrus on gentamicin-induced nephrotoxicity in rats. Indian J Pharmacol 46(3):298–302CrossRef Kakalij RM, Alla CP, Kshirsagar RP, Kumar BH, Mutha SS, Diwan PV (2014) Ameliorative effect of Elaeocarpus ganitrus on gentamicin-induced nephrotoxicity in rats. Indian J Pharmacol 46(3):298–302CrossRef
36.
Zurück zum Zitat Soni H, Kaminski D, Gangaraju R, Adebiyia A (2018) Cisplatin-induced oxidative stress stimulates renal Fas ligand shedding. Ren Fail 40(1):314–322CrossRef Soni H, Kaminski D, Gangaraju R, Adebiyia A (2018) Cisplatin-induced oxidative stress stimulates renal Fas ligand shedding. Ren Fail 40(1):314–322CrossRef
37.
Zurück zum Zitat Mahmoud AM, Hussein OE, El-Twab SMA, Hozayen WG (2019) Ferulic acid protects against methotrexate nephrotoxicity via activation of Nrf2/ARE/HO-1 signaling and PPARγ, and suppression of NF-κB/NLRP3 inflammasome axis. Food Funct. 10:4593–4607CrossRef Mahmoud AM, Hussein OE, El-Twab SMA, Hozayen WG (2019) Ferulic acid protects against methotrexate nephrotoxicity via activation of Nrf2/ARE/HO-1 signaling and PPARγ, and suppression of NF-κB/NLRP3 inflammasome axis. Food Funct. 10:4593–4607CrossRef
38.
Zurück zum Zitat Zhou YD, Hou JG, Yang G, Jiang S, Chen C et al (2019) Icariin ameliorates cisplatin-induced cytotoxicity in human embryonic kidney 293 cells by suppressing ROS-mediated PI3K/Akt pathway. Biomed Pharmacother 109:2309–2317CrossRef Zhou YD, Hou JG, Yang G, Jiang S, Chen C et al (2019) Icariin ameliorates cisplatin-induced cytotoxicity in human embryonic kidney 293 cells by suppressing ROS-mediated PI3K/Akt pathway. Biomed Pharmacother 109:2309–2317CrossRef
39.
Zurück zum Zitat Siwik DA, Pagano PJ, Colucci WS (2001) Oxidative stress regulates collagen synthesis and matrix metalloproteinase activity in cardiac fibroblasts. Am J Physiol Cell Physiol 280:C53–C60CrossRef Siwik DA, Pagano PJ, Colucci WS (2001) Oxidative stress regulates collagen synthesis and matrix metalloproteinase activity in cardiac fibroblasts. Am J Physiol Cell Physiol 280:C53–C60CrossRef
41.
Zurück zum Zitat Ruetten H, Dimmeler S, Gehring D, Ihling C, Zeiher AM (2005) Concentric left ventricular remodeling in endothelial nitric oxide synthase knockout mice by chronic pressure overload. Cardiovasc Res 66:444–453CrossRef Ruetten H, Dimmeler S, Gehring D, Ihling C, Zeiher AM (2005) Concentric left ventricular remodeling in endothelial nitric oxide synthase knockout mice by chronic pressure overload. Cardiovasc Res 66:444–453CrossRef
42.
Zurück zum Zitat Lucarini L, Durante M, Lanzi C, Pini A, Boccalini G, Calosi L, Moroni F, Masini E, Mannaioni G (2017) HYDAMTIQ, a selective PARP-1 inhibitor, improves bleomycin-induced lung fibrosis by dampening the TGF-b/SMAD signalling pathway. J Cell Mol Med 21(2):324–335CrossRef Lucarini L, Durante M, Lanzi C, Pini A, Boccalini G, Calosi L, Moroni F, Masini E, Mannaioni G (2017) HYDAMTIQ, a selective PARP-1 inhibitor, improves bleomycin-induced lung fibrosis by dampening the TGF-b/SMAD signalling pathway. J Cell Mol Med 21(2):324–335CrossRef
Metadaten
Titel
Role of rivaroxaban in sunitinib-induced renal injuries via inhibition of oxidative stress-induced apoptosis and inflammation through the tissue nacrosis factor-α induced nuclear factor-κappa B signaling pathway in rats
verfasst von
Naif O. Al-Harbi
Faisal Imam
Mohammad Matar Alharbi
Mohammad Rashid Khan
Wajhul Qamar
Muhammad Afzal
Mohammad Algahtani
Saad Alobaid
Ali Salim Alfardan
Abdulrahman Alshammari
Thamer H. Albekairi
Khalid Saad Alharbi
Publikationsdatum
01.05.2020
Verlag
Springer US
Erschienen in
Journal of Thrombosis and Thrombolysis / Ausgabe 2/2020
Print ISSN: 0929-5305
Elektronische ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-020-02123-6

Kompaktes Leitlinien-Wissen Innere Medizin (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Neu im Fachgebiet Innere Medizin

Lipidtherapie im Praxisalltag: Noch viel Spielraum für Verbesserung

Wie steht es um die Behandlung von Dyslipidämien bei Risikopatienten mit atherosklerotischer Gefäßerkrankung in Deutschland? Eine Bestandsaufnahme dazu liefert das bei der DGK-Tagung 2025 vorgestellte Forschungsprojekt LipidSnapshot.

Lohnt sich die Karotis-Revaskularisation?

Die medikamentöse Therapie für Menschen mit Karotisstenosen hat sich in den vergangenen Dekaden verbessert. Braucht es also noch einen invasiven Eingriff zur Revaskularisation der Halsschlagader bei geringem bis moderatem Risiko für einen ipsilateralen Schlaganfall?

Höhere Dosis von Dexamethason senkt Überlebenschancen

Personen mit Hirnmetastasen, die perioperativ höhere kumulative Dosen von Dexamethason erhalten, haben eine schlechtere Prognose. Um die Ergebnisse zu verbessern, bedarf es strengerer Dosierungsschemata.

Schützen GLP1-Rezeptor-Agonisten vor kardiovaskulären Komplikationen nach Pneumonie?

Kardiovaskuläre Ereignisse nach Lungeninfektionen sind häufig, doch pathophysiologisch wenig verstanden. Dass womöglich Glukagon daran Anteil hat, eröffnet neue therapeutische Perspektiven.

EKG Essentials: EKG befunden mit System (Link öffnet in neuem Fenster)

In diesem CME-Kurs können Sie Ihr Wissen zur EKG-Befundung anhand von zwölf Video-Tutorials auffrischen und 10 CME-Punkte sammeln.
Praxisnah, relevant und mit vielen Tipps & Tricks vom Profi.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.